Effects of hormone replacement therapy on postmenopausal uterine myoma

被引:24
|
作者
Colacurci, N
De Franciscis, P
Cobellis, L
Nazzaro, G
De Placido, G
机构
[1] Univ Naples 2, Sch Med, Outpatient Menopausal Clin, Inst Obstet & Gynaecol, I-80134 Naples, Italy
[2] Univ Naples Federico II, Dept Emergency Obstet & Gynaedol & Reprod Med, Ultrasound Unit, I-80100 Naples, Italy
关键词
Doppler; hormone replacement therapy; myoma; postmenopause; ultrasonography;
D O I
10.1016/S0378-5122(00)00115-8
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: To evaluate the effects of sequential continuous hormone replacement therapy (HRT) on myoma size and on pulsatility index (PI) of uterine arteries and to verify the correlation between uterine artery flow impedance and the growth rate of myoma in women receiving HRT. Methods: In a prospective 1-year study 60 postmenopausal women were enrolled into three study-groups to receive continuous transdermal 17 beta-oestradiol 0.05 mg/day plus nomegestrolo acetate 5 mg/day sequentially added: 20 patients (group A) unaffected by uterine myomas, 20 patients (group B) with single asymptomatic myoma < 3 cm/14 cm(3), 20 patients (group C) with single asymptomatic myoma > 3 cm/14 cm(3). The changes in myoma volume and in PI were assessed by means of transvaginal ultrasonographic scan every 3 months. The patients with myoma were divided into two subgroups: quiescent myoma (B1, C1) and growing myoma (B2, C2). Results: No significant increase of uterine fibroids volume was found after I-year HRT (24.14 +/- 20.02 --> 28.81 +/- 30.02 cm(3)). Six out of eight myomas growing during HRT belonged to group C. The uterine artery basal PI value of group A was significantly higher (P < 0.01) than the corresponding PI in group B and C. At 3 months Follow-up, uterine artery PI was significantly higher (P < 0.01) than the basal value in both group 8 (1.70 +/- 0.22 --> 1.88 +/- 0.16) and C (1.59 +/- 0.28 --> 1.92 +/- 0.21). The baseline PI values in group B1 and C1 were lsignificantly higher than the baseline values observed in group B2 and C2 (1.76 +/- 0.17 vs. 1.32 +/- 0.02, 1.76 +/- 0.16 vs. 1.24 +/- 0.08) and significantly lower than those observed in group A (2.39 +/- 0.47). After 3 months of HRT, the PI values were not significantly higher than the baseline values in groups B1 and C2 (1.76 +/- 0.17 --> 1.90 +/- 0.17; 1.24 +/- 0.08 --> 1.74 +/- 0.16), while they were significantly higher in group C1 (1.76 +/- 0.16 --> 2.01 +/- 0.17). Conclusions: Sequential continuous HRT does not increase the volume of the uterine myoma. The findings of very low resistance index in the uterine arteries of women with growing myoma may indicate the risk of growth of the neoplasia during HRT. The assessment of PI in the uterine arteries could be helpful in predicting the growth rate of the myomas before starting HRT. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 50 条
  • [41] Hysteroscopy in women with abnormal uterine bleeding on hormone replacement therapy: A comparison with postmenopausal bleeding
    Nagele, F
    OConnor, H
    Baskett, TF
    Davies, A
    Mohammed, H
    Magos, AL
    FERTILITY AND STERILITY, 1996, 65 (06) : 1145 - 1150
  • [42] Diagnosis and treatment of abnormal uterine bleeding in postmenopausal patients using hormone replacement therapy
    Maia, H
    Maltez, A
    Oliveira, M
    Calmon, LC
    Coutinho, EM
    GYNAECOLOGICAL ENDOSCOPY, 1998, 7 (06) : 319 - 325
  • [43] Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy
    Johnson, JV
    Davidson, M
    Archer, D
    Bachmann, G
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2002, 9 (01): : 16 - 22
  • [44] Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period - Tibolone versus transdermal hormonal replacement system
    Simsek, T
    Karakus, C
    Trak, B
    MATURITAS, 2002, 42 (03) : 243 - 246
  • [45] GENITAL TUBERCULOSIS IN A POSTMENOPAUSAL PATIENT WITH UTERINE MYOMA
    GOOVAERTS, G
    GOOSSENS, A
    DEBRUCKER, P
    ACTA CLINICA BELGICA, 1985, 40 (05): : 318 - 321
  • [46] Additive effects of simvastatin and hormone replacement therapy in hypercholesterolemic postmenopausal women
    Fak, AS
    Erenus, M
    Tezcan, H
    Caymaz, O
    Atagündüz, P
    Tokay, S
    Toprak, A
    Oktay, S
    Oktay, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (01) : 311 - 312
  • [47] PARADOXICAL EFFECTS OF HORMONE REPLACEMENT THERAPY ON BREAST TENDERNESS IN POSTMENOPAUSAL WOMEN
    MARSH, MS
    WHITCROFT, S
    WHITEHEAD, MI
    MATURITAS, 1994, 19 (02) : 97 - 102
  • [48] Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women
    Chen, FP
    Lee, N
    Wang, CH
    Cherng, WJ
    Soong, YK
    FERTILITY AND STERILITY, 1998, 69 (02) : 267 - 273
  • [49] Effects of hormone replacement therapy on cancellous bone microstructure in postmenopausal women
    Vedi, S
    Croucher, PI
    Garrahan, NJ
    Compston, JE
    BONE, 1996, 19 (01) : 69 - 72
  • [50] The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival
    Sener, Stephen F.
    Winchester, David J.
    Winchester, David P.
    Du, Hongyan
    Barrera, Ermilo
    Bilimoria, Malcolm
    Krantz, Seth
    Rabbitt, Sarah
    AMERICAN JOURNAL OF SURGERY, 2009, 197 (03): : 403 - 406